K.C. Pharmaceuticals, a California-based company, has expanded its eye drop recall to include more than three million bottles across the United States. The recall, which began about a month ago, was prompted by concerns over a lack of assurance of sterility in the affected products.
Eight different types of eye drops are now included on the recall list. At this time, there have been no reported negative health impacts related to the recalled products.
Consumers seeking more information or wishing to check if their eye drops are included in the recall can visit the FDA’s official website at fda.gov.